Zhejiang Xinguang Pharmaceutical Co.,Ltd.’s Net Profit Rose 1.6% in First Three Quarters of 2022

Zhejiang Xinguang Pharmaceutical Co.,Ltd. (浙江新光药业股份有限公司) (300519.SZ) reported a net profit of 89.4 million yuan in the first three quarters of 2022, up 1.6% year-on-year.

Meanwhile, the company posted 262.5 million yuan in revenue, up 6.6% year-on-year.

At the end of the reporting period, it had 925.6 million yuan in total assets and 86.3 million yuan in total liabilities, with a liability-to-asset ratio of 9.3%.